Global Bio Simulation Market Overview:
Bio simulation denotes simulation of the dynamics of biological systems. It analyzes and predicts system behavior in terms of mathematical expression with the help of modern computers. Bio simulation is a relatively new tool in pharmaceutical drug development & healthcare that has tremendous benefits and improves the predictability in the early stages of drug development. Bio simulation uses a mathematical representation of the real-life processes inside the human body that are expressed in interconnected sets of differential equations. The various technological advancements and increasing occurrences of various chronic diseases will contribute the market growth in the coming years. Some of the players profiled in the study are Certara (United States), Simulations Plus (United States), Dassault Systèmes (France), Schrödinger (United States), ACD/Labs (Canada), Chemical Computing Group (Canada), Physiomics (United Kingdom), Evidera (United States), In silico biosciences (United States), INOSIM Software (Germany), Insilico Biotechnology (Germany), LeadInvent Technologies (India), Rosa (United States), Nuventra Pharma (United States) and Genedata (Switzerland). According to Market Analyst at AMA, the Global Bio Simulation market may see a growth rate of 16.02%
On the basis of geography, the market of Bio Simulation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Users, the sub-segment i.e. Pharmaceutical & Biotechnology Companies will boost the Bio Simulation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Delivery Model, the sub-segment i.e. Subscription Models will boost the Bio Simulation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Growth Drivers
- Growth Of Pharmaceutical And Biotech Industries
- Increasing Adoption Of Bio Simulation Software By Regulatory Bodies
- Rising Growth Of Biologics And Biosimilars Markets
Influencing Trend
- Technological Advancement QSP Systems
Restraints
Opportunities
- Government Investments In R&D
- Need to Decrease Drug Discovery and Development Costs
- Demand For Personalized Medicines
Challenges
- Shortage Of Bio Simulation And Modeling Experts
Key Market Developments:
In June 2020, Certara launched updation of its Phoenix platform, a bio simulation software for drug development. The Phoenix platform version 8.3 updation includes Phoenix NLME, Phoenix Built-In Plots, and Open Source Plotting.
The intense competition, changing consumer spending patterns, demographic trends, and increasing investments by key players pose significant growth opportunities for the global bio simulation market in forecast years.
Target Audience:
New Entrants/Investors, Analysts and Strategic Business Planners, Bio Simulation Providers, Software Providers, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End Use Industry
Major Objectives Focused through this Study
To define, describe, and forecast the Global Bio Simulation market on the basis of product [Software {Molecular Modeling and Simulation Software, PBPK Modeling and Simulation Software, PK/PD Modeling and Simulation Software, Trial Design Software, Toxicity Prediction Software, Other} and Services {In-house Services, Contract Services}] , application [Drug Development {Preclinical Testing, Clinical Trials}, Drug Discovery{ Target Identification and Validation, Lead Identification and Optimization} and Other], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Bio Simulation market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Bio Simulation industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are
.** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Bio Simulation market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.